MENU

Suzanne Miller Appointed Next Editor of Translational Behavioral Medicine

September 1, 2015

PHILADELPHIA (September 1, 2015) – Suzanne M. Miller, PhD, has been appointed the next editor-in-chief of Translational Behavioral Medicine: Practice, Policy, Research, a journal of the Society of Behavioral Medicine.

Dr. Miller’s career has focused on psychology and oncology. She is a professor of cancer prevention and control at Fox Chase Cancer Center, where she also serves as director of the Psychosocial and Bio-Behavioral Medicine Department.

Translational Behavioral Medicine (TBM) fills an important niche by bringing actionable science to practitioners and by prompting debate on policy issues that surround the dissemination and implementation of evidence-based health interventions.

TBM began publishing in 2011 and has experienced significant growth.  Approximately 300 articles have been published, and 70,000 article PDFs have been downloaded. The journal is indexed in 15 services including PubMed Central and Thomson Reuters products.

Dr. Miller plans to extend the journal’s impact by highlighting its dissemination focus, growing its Web presence, increasing the international distribution of editors for more worldwide impact, and partnering with policy makers to share journal content and dialogue with providers, consumers, and payers.

“I have an abiding commitment to the diffusion and dissemination of behavioral science and public health contributions,” Dr. Miller says. “TBM holds an important and unique place among behavioral medicine and public health journals: its focus is on actionable science that positively impacts provider, patient, and population outcomes across a spectrum of health conditions. My goal is to move this journal forward so that it is directly consequential to patient experience and systems and quality of care.”

Dr. Miller founded the Department of Defense-funded Behavioral Center of Excellence in Breast Cancer and directed one of the country’s first National Cancer Institute-funded behavioral core facilities. Her research has been funded continuously for more than 35 years. Her recent National Institutes of Health (NIH) grants include two grants to study an online multimedia program to boost coping and function in cancer survivors in the oncologic and primary contexts, respectively, and another to enhance decision making about cancer treatments among low health literacy populations. Dr. Miller also has substantial experience with the grant review process and is currently a standing member of the NIH Behavioral Medicine Intervention and Outcomes Study Section.

Dr. Miller is a Society of Behavioral Medicine fellow who has served on the society’s Board of Directors and received its C. Tracy Orleans Distinguished Service Award and Cancer Special Interest Group Outstanding Senior Scientist Award.

Dr. Miller comes to her new editor post with significant editorial experience. She has been guest editor for several journals, including Cancer, Annals of Behavioral Medicine, and Journal of Health Communication. She has served on editorial boards for more than 10 journals and is a frequent reviewer for nearly 40 scientific publications.  Her most recent book is the handbook of Health Decision Science (in press with Springer) and she is a permanent member of the Behavioral Medicine Interventions and Outcomes Study Section.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

       

Connect with Fox Chase